Substance Use Disorders and Psychiatric Comorbidity
K. Taleb, F. Laajili, H. Ballouk, Z. Bencharfa, F. El OmariIntroduction
Substance use disorders (SUDs) are often associated with other mental disorders—psychotic, mood, or anxiety—complicating treatment and worsening clinical and social outcomes.
Objectives
To describe the main psychiatric comorbidities among patients with SUDs and examine their relationship with substance type.
Methods
A retrospective descriptive study based on clinical records of patients consulting for SUDs. Collected data included sociodemographic profile, substances used, psychiatric diagnoses, and treatments.
Results
Results (N = 102):
Gender: predominantly male (~90%). Age: mostly 20–40 years. Main substances: tobacco (85%), cannabis (70%), alcohol (56%). Comorbid disorders: psychotic (45%), mood (30%), anxiety (15%), personality (10%). Polysubstance use: >50% of patients. Treatments: antipsychotics (79%), antidepressants (55%), anxiolytics (38%).
Conclusions
SUDs are commonly associated with severe psychiatric comorbidities. Systematic screening and a dual-diagnosis approach are key to enhancing prognosis and patient reintegration.
Disclosure of Interest
None Declared